	Comparative Efficacy and Safety of First-Line Immune Checkpoint Inhibitors Plus Chemotherapy with or Without Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Carcinoma. Curr Oncol Chen P, Wang M, Peng S, Zhu H, Wang Y, Wan Z, Yang X, Yu Z, Zhou Y. PMID: 41892201 [PubMed - indexed for MEDLINE]
	Knowledge and Awareness of the General Public on Lung Cancer Screening Modalities and Lung Cancer Preventive Methods in Riyadh, Saudi Arabia. Curr Oncol Kaaki S, Alkhani K, Aldosari O, Aldosari Z, Alhuqbani M, Nagshabandi K, Hajjar AW, Al-Nassar SA, Hajjar WM. PMID: 41892197 [PubMed - indexed for MEDLINE]
	Real-World Treatment Patterns and Survival in Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe. Curr Oncol Cheung WY, Lee A, Bote de Cabo H, Burdenski K, Christopoulos P, Pinto-Correia B, Deshayes S, Girard N, Hindocha P, Madden Á, Mella M, Moreira J, Rizzi S, Abreu DR, Soares M, Thomas J, Han M, Calvet CY, Emanuel G, Glassberg MB, Jacobs H, Rault C, Yuan Y, Chouaid C. PMID: 41892180 [PubMed - indexed for MEDLINE]
	PD-L1 Negative Advanced Non-Small Cell Lung Cancer: Practice Patterns and Real-World Outcomes. Curr Oncol Bégin AA, Dubé-Pelletier M, Labbé C, Mai V, Maranda-Robitaille M, Denault MH. PMID: 41892172 [PubMed - indexed for MEDLINE]
	Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers. Curr Oncol Miura Y, Imai H, Endo S, Hashimoto K, Yamaguchi O, Mouri A, Masubuchi K, Masubuchi T, Fujita Y, Kato S, Kagamu H, Kaira K. PMID: 41892163 [PubMed - indexed for MEDLINE]
	Hyalinizing clear cell carcinoma of the lung: A rare case with long-term follow-up. Tuberk Toraks Ocak , Ufuk F, Husain A. PMID: 41891650 [PubMed - indexed for MEDLINE]
	Association between metabolic activity and molecular alterations in lung adenocarcinoma: Insights from 18F-FDG PET/CT. Tuberk Toraks Yi, Argüner H, Ba, , Gököz G, Aydo, Bir F, Gültekin A. PMID: 41891647 [PubMed - indexed for MEDLINE]
	Unraveling the nexus: Tumor mutational burden, PD-L1 expression, and oncogenic alterations in non-small cell lung cancer cytology specimens. Cancer Cytopathol Dai M, San Lucas FA, Alvarez H, Ballester L, Chen H, Patel KP, Rashid A, Rao S, Routbort MJ, Sura G, Sweeney K, Toruner G, Wei P, Yang R, Dang H, Luthra R, Roy-Chowdhuri S. PMID: 41891376 [PubMed - indexed for MEDLINE]
	Post-translational protein lactylation modification in lung cancer: an emerging targeted therapeutic strategy. Front Immunol Li Y, Li Z, Liu X, Qiu Z, Zhang R, Li H, Gao C, Guo C. PMID: 41890749 [PubMed - indexed for MEDLINE]
	Small cell lung cancer: from immunobiological mechanisms to clinical advances. Front Immunol Zhong X, Ji P, Yang L. PMID: 41890737 [PubMed - indexed for MEDLINE]
	Serum ferritin change rate combined with a multidimensional inflammation model for predicting efficacy and survival in extensive-stage small-cell lung cancer patients undergoing immunotherapy: a single-center, retrospective cohort study. Front Immunol Liu Y, Liu X, Li Y, Li M, Su Y, Chen P. PMID: 41890728 [PubMed - indexed for MEDLINE]
	Refractory hyponatremia in small cell lung cancer: a case report and literature review. Front Endocrinol (Lausanne) Bao S, Qin L, Zhang Y, Jiang X, Duan L. PMID: 41890180 [PubMed - indexed for MEDLINE]
	Beyond Histology: A Unified Transcriptomic Atlas Defines Lung Cancer Biologic States and Subtypes. bioRxiv Arora S, Suresh L, Thirimanne HN, Glatzer G, Jensen M, Fatherree JP, Konnick EQ, Levine KM, Brooks AN, Hougton AM, Pritchard CC, MacPherson D, Berger AH, Holland EC. PMID: 41890019 [PubMed]
	Association and predictive value of sarcopenic obesity for the prognosis of lung cancer patients receiving immune checkpoint inhibitors. Front Nutr Yang T, Wang W, Qiao Y, Guan K, Wang W, Yang Y, Chen Y, Shen L. PMID: 41889724 [PubMed]
	An evolving landscape: predictive and therapeutic biomarkers in advanced non-small cell lung cancer. Front Oncol Fortman D, Qin A. PMID: 41889421 [PubMed]
	Initial Site of Metastasis Influences Prognosis in Pancreatic Ductal Adenocarcinoma. Cancer Med Mancheski E, Baek D, Bowne W, Lavu H, Yeo CJ, Nevler A. PMID: 41889072 [PubMed - indexed for MEDLINE]
	Pleural-Based GLI1-Altered Mesenchymal Tumor With ACTB-GLI1 Fusion: A Rare Pulmonary Entity Mimicking Synovial Sarcoma. Thorac Cancer Lizwan M, Xiao L, Chow CY, Lau HY, Ong BH. PMID: 41888999 [PubMed - indexed for MEDLINE]
	Thermal modulation enhances antitumour immunity and improves immunotherapy responses in lung cancer. Discov Oncol Lin L, Gao Y, Ge X, Mao Y, Zhai J, Jia Y, Sheng S, Qin B, Wang J. PMID: 41888280 [PubMed - as supplied by publisher]
	Huge lung-cancer screening campaign boosts early diagnosis. Nature PMID: 41888264 [PubMed - as supplied by publisher]
	Comment on "Consensus of the Taiwanese dermatological association and Taiwan lung cancer society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience.". J Formos Med Assoc Shivaraj DR. PMID: 41888010 [PubMed - as supplied by publisher]

Articles 1 - 20 / 157484

Page 1 of 7875



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy